Literature DB >> 22613410

Enhanced T cell immunity by B7-H4 downregulation in nonsmall-cell lung cancer cell lines.

S-Q Sun1, C-G Jiang, Y Lin, Y-L Jin, P-L Huang.   

Abstract

OBJECTIVES: T cell immunity plays a critical role in host immune surveillance of tumour cell growth and metastatic spread. This study used small hairpin (sh)RNA-mediated gene silencing to target VTCN1 (B7-H4) expression in a nonsmall-cell lung cancer (NSCLC) cell line (A549) and evaluated the effects on T cell immune activity using an in vitro coculture system.
METHODS: VTCN1-specific shRNA-expressing plasmid was transfected into A549 cells. Mock transfected and empty plasmid-transfected A549 cells served as controls. VTCN1 expression in A549 cells was determined by reverse transcription-polymerase chain reaction (RT-PCR) for VTCN1 mRNA and Western blotting for B7-H4 protein. Transfected A549 cells were cocultured with Jurkat cells. Jurkat cells were examined for proliferation, apoptosis, cell cycle distribution and intracellular cytokine mRNA and protein levels.
RESULTS: VTCN1-specific shRNA efficiently knocked down VTCN1 mRNA and B7-H4 protein levels in A549 cells. This downregulation led to enhanced Jurkat cell proliferation, decreased apoptosis, stimulated cell cycle progression and elevated production of interferon-γ, interleukin (IL)-10 and IL-2.
CONCLUSIONS: B7-H4 negatively regulates T cell-mediated antitumour immunity in NSCLC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22613410     DOI: 10.1177/147323001204000211

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  6 in total

Review 1.  B7-H4 as a potential target for immunotherapy for gynecologic cancers: a closer look.

Authors:  Jenessa B Smith; Caitlin Stashwick; Daniel J Powell
Journal:  Gynecol Oncol       Date:  2014-03-20       Impact factor: 5.482

Review 2.  B7 family checkpoint regulators in immune regulation and disease.

Authors:  Sabrina Ceeraz; Elizabeth C Nowak; Randolph J Noelle
Journal:  Trends Immunol       Date:  2013-08-13       Impact factor: 16.687

3.  Role of B7-H4 siRNA in Proliferation, Migration, and Invasion of LOVO Colorectal Carcinoma Cell Line.

Authors:  Hai-Xia Peng; Wei-Qi Wu; Da-Ming Yang; Rong Jing; Ji Li; Feng-Li Zhou; Yun-Fei Jin; Sai-Yu Wang; Yi-Min Chu
Journal:  Biomed Res Int       Date:  2015-05-21       Impact factor: 3.411

4.  Inhibition of mouse SP2/0 myeloma cell growth by the B7-H4 protein vaccine.

Authors:  Nan Mu; Nannan Liu; Qiang Hao; Yujin Xu; Jialin Li; Weina Li; Shouzhen Wu; Cun Zhang; Haichuan Su
Journal:  BMB Rep       Date:  2014-07       Impact factor: 4.778

5.  Downregulation of B7-H4 in the MHCC97-H hepatocellular carcinoma cell line by arsenic trioxide.

Authors:  Liming Cui; Bo Gao; Zhigang Cao; Xiaoying Chen; Shide Zhang; Weizhe Zhang
Journal:  Mol Med Rep       Date:  2016-01-12       Impact factor: 2.952

6.  Effect of A549 neuroendocrine differentiation on cytotoxic immune response.

Authors:  Irasema Mendieta; Rosa Elvira Nuñez-Anita; Gilberto Pérez-Sánchez; Lenin Pavón; Alfredo Rodríguez-Cruz; Guadalupe García-Alcocer; Laura Cristina Berumen
Journal:  Endocr Connect       Date:  2018-04-26       Impact factor: 3.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.